Literature DB >> 1381037

Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas.

M Kita1, Y Ohmoto, Y Hirai, N Yamaguchi, J Imanishi.   

Abstract

Various species of mycoplasmas were tested for their ability to induce cytokine production in human peripheral blood mononuclear cells (PBMC). Human PBMC were incubated with Mycoplasma pneumoniae, M. hyorhinis, M. arginini, M. salivarium, M. orale, M. gallisepticum or A. laidlawii for 48 hr, and the activities of interleukin-1 beta (IL-1 beta), IL-2, IL-4, IL-6, tumor necrosis factor-alpha (TNF-alpha) and interferon (IFN) in the supernatants were determined by ELISA or bioassay. All mycoplasma species induced IL-1 beta, IL-6 and TNF-alpha, although IL-2 was induced only by M. pneumoniae. IFN was induced by 5 of the 7 species, and the IFN produced was antigenically confirmed to be mainly IFN-alpha. On the other hand, mycoplasma-stimulated cultures did not contain detectable amounts of IFN-beta and IL-4 activities. Furthermore, the cytokines were induced by mycoplasmal contaminating cells in human PBMC as well as by mycoplasma alone. These results suggest that many kinds of cytokines induced by mycoplasma contamination in cell culture affect immunological experiments in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381037     DOI: 10.1111/j.1348-0421.1992.tb02048.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  23 in total

1.  Activation of human monocytes for enhanced production of interleukin 8 during transendothelial migration in vitro.

Authors:  M Takahashi; U Ikeda; T Kasahara; S Kitagawa; Y Takahashi; K Shimada; S Kano; C Morimoto; J Masuyama
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

2.  cDNA and genomic cloning and expression of the P48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product.

Authors:  R E Hall; S Agarwal; D P Kestler; J A Cobb; K M Goldstein; N S Chang
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

3.  Lipid extract of Mycoplasma penetrans proteinase K-digested lipid-associated membrane proteins rapidly activates NF-kappaB and activator protein 1.

Authors:  S H Feng; S C Lo
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2.

Authors:  A Kaufmann; P F Mühlradt; D Gemsa; H Sprenger
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Cytokines in Mycoplasma hyorhinis-induced arthritis in pigs bred selectively for high and low immune responses.

Authors:  N R Jayagopala Reddy; B N Wilkie; P Borgs; B A Mallard
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Stimulation of nitric oxide production in macrophages by Babesia bovis.

Authors:  R W Stich; L K Shoda; M Dreewes; B Adler; T W Jungi; W C Brown
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells.

Authors:  Hua Yang; Like Qu; Huachong Ma; Ling Chen; Wenbin Liu; Caiyun Liu; Lin Meng; Jian Wu; Chengchao Shou
Journal:  BMC Gastroenterol       Date:  2010-11-10       Impact factor: 3.067

Review 8.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

9.  Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes.

Authors:  A Herbelin; E Ruuth; D Delorme; C Michel-Herbelin; F Praz
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Mycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide.

Authors:  G Rawadi; S Roman-Roman
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.